查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1482417

單細胞分析市場：依產品類型、最終用戶、地區 - 全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2032 年

Single-Cell Analysis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 301 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究詳細分析了單細胞分析市場，並提供了對其多方面動態和預期未來趨勢的深入見解。這份綜合報告涵蓋了市場發展、驅動因素、障礙和新興模式，並提供了 2024 年至 2032 年的關鍵統計數據和預測。

關鍵見解

  • 單細胞分析市場規模（2024 年）：57 億美元
  • 預測市場規模（2032 年）：245.2 億美元
  • 全球市場成長率（複合年增長率，2024-2032）：23.17%

單細胞分析市場 - 研究範圍：

該市場由各種應用組成，這些應用對於增進我們對細胞異質性和疾病機制的理解至關重要。單細胞分析技術使研究人員能夠在細胞層面剖析複雜的生物系統，深入瞭解細胞多樣性、基因表現譜和生物標記識別。由於單細胞分析在癌症研究、免疫學、神經科學和幹細胞生物學等各領域的應用不斷擴大，該市場正在顯著成長。此外，單細胞分析平台的技術進步和生命科學研究投資的增加正在推動市場擴張。

推動市場成長的因素：

推動單細胞分析市場成長的因素很多。對高解析度細胞分析工具的需求不斷增長，以破解癌症和神經退化性疾病等疾病中的細胞異質性，這是一個關鍵驅動因素。此外，單細胞定序技術的進步，例如基於液滴的方法和空間轉錄組學，正在擴大單細胞分析應用的範圍。此外，學術研究機構、製藥公司和技術提供者之間的合作正在推動單細胞分析平台的創新並推動市場成長。

市場限制因素：

儘管單細胞分析市場前景廣闊，仍面臨一些課題。高設備成本和數據分析的複雜性是單細胞分析技術廣泛採用的主要障礙，特別是在資源有限的環境中。此外，單細胞數據的解釋和實驗方案的標準化仍然是研究人員面臨的重要課題。此外，對數據再現性的擔憂以及對強有力的品質控制措施的需求也在一定程度上阻礙了市場的成長。

市場機會：

單細胞分析市場充滿了創新和成長的機會。單細胞分離技術的進步，加上多組學方法的整合，有可能擴大單細胞分析在個人化醫療和藥物發現的應用領域。此外，單細胞空間分析技術的出現為研究各種病理條件下的組織微環境和細胞間相互作用提供了新的途徑。此外，技術開發商和製藥公司之間的策略聯盟開發新型單細胞分析方法和生物標記發現平台可能會推動市場擴張。

本報告解決的關鍵問題

  • 推動單細胞分析市場全球成長的關鍵因素是什麼？
  • 技術進步如何影響單細胞分析技術的開發與採用？
  • 市場參與者面臨的主要課題和機會是什麼？
  • 哪些研究領域和治療應用預計將出現最高成長？
  • 領先公司正在採取哪些策略來鞏固其市場地位並滿足研究人員和臨床醫生不斷變化的需求？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第三章市場背景

  • 市場動態
  • 情境預測
  • 機會圖分析
  • 投資可行性矩陣
  • PESTLE 和 Porter 分析
  • 監理狀況
  • 依地區劃分的母公司市場前景

第四章全球單細胞分析市場分析

  • 過去的市場規模金額分析，2019-2023 年
  • 目前與未來的市場規模預測：2024-2032 年
    • 年成長趨勢分析
    • 絕對數量機會分析

第五章全球單細胞分析市場分析：依產品

  • 簡介/主要發現
  • 過去的市場規模貨幣分析：依產品分類，2019-2023 年
  • 2024-2032 年依產品劃分的當前和未來市場規模貨幣分析和預測
    • 消耗品
    • 設備
  • 年成長趨勢分析：依產品分類，2019-2023 年
  • 絕對價值機會分析：依產品分類，2024-2032 年

第六章全球單細胞分析市場分析：依應用

  • 簡介/主要發現
  • 過去的市場規模金額分析：依應用劃分，2019-2023 年
  • 當前和未來的市場規模貨幣分析和預測：依應用劃分，2024 年至 2032 年
    • 癌症
    • 免疫學
    • 神經病學
    • 幹細胞
    • 無創產前診斷
    • 體外受精
    • 其他
  • 年成長趨勢分析：依應用分類，2019-2023 年
  • 絕對機會分析：依應用分類，2024-2032 年

第 7 章全球單細胞分析市場分析：依工作流程

  • 簡介/主要發現
  • 過去的市場規模貨幣分析：依工作流程，2019-2023 年
  • 當前和未來的市場規模貨幣分析和預測：依工作流程劃分，2024-2032 年
    • 單細胞分離/文庫製備
    • 下游分析
    • 資料分析
  • 年成長趨勢分析：依工作流程劃分，2019-2023 年
  • 絕對價值機會分析：依工作流程劃分，2024-2032 年

第 8 章全球單細胞分析市場分析：依最終使用者劃分

  • 簡介/主要發現
  • 過去的市場規模金額分析：以最終用戶劃分，2019-2023 年
  • 當前和未來的市場規模貨幣分析和預測：依最終用戶劃分，2024-2032 年
    • 學術/研究機構
    • 生技/製藥公司
    • 醫院/診斷實驗室
    • 其他
  • 年成長趨勢分析：依最終用戶劃分，2019-2023 年
  • 絕對價值機會分析：依最終使用者劃分，2024-2032 年

第 9 章全球單細胞分析市場分析：依地區

  • 簡介
  • 過去的市場規模分析：依地區劃分，2019-2023 年
  • 當前市場規模貨幣分析與預測：依地區劃分，2024-2032 年
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 市場吸引力分析：依地區劃分

第 10 章北美單細胞分析市場分析：依國家

第 11 章依國家劃分的拉丁美洲單細胞分析市場分析

第 12 章歐洲單細胞分析市場分析：依國家

第 13 章亞太地區單細胞分析市場國家分析

第 14 章中東和非洲單細胞分析市場分析：依國家

第十五章主要國家單細胞分析市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 中國
  • 日本
  • 韓國
  • 新加坡
  • 泰國
  • 印尼
  • 澳大利亞
  • 紐西蘭
  • 海灣合作委員會國家
  • 南非
  • 以色列

第十六章市場結構分析

  • 競爭對手儀表板
  • 競爭基準
  • 主要公司市佔率分析

第十七章競爭分析

  • 衝突詳情
    • Thermo Fisher Scientific, Inc.
    • QIAGEN NV
    • Bio-Rad Laboratories Inc.
    • Illumina Inc.
    • Merck KGaA
    • Becton, Dickinson &Company
    • Fluidigm Corporation
    • 10x Genomics, Inc.
    • BGI
    • Novogene Corporation

第 18 章先決條件與使用的縮寫

第十九章研究方法

簡介目錄
Product Code: PMRREP33180

Persistence Market Research provides an in-depth analysis of the Single-Cell Analysis Market, offering detailed insights into its multifaceted dynamics and projected future trends. This comprehensive report encompasses market developments, driving forces, hurdles, and emerging patterns, furnishing crucial statistics and forecasts from 2024 to 2032.

Key Insights:

  • Single-Cell Analysis Market Size (2024): USD 5.70 Billion
  • Projected Market Value (2032): USD 24.52 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 23.17%

Single-Cell Analysis Market - Report Scope:

The market comprises various applications crucial for advancing our understanding of cellular heterogeneity and disease mechanisms. Single-cell analysis technologies enable researchers to dissect complex biological systems at the cellular level, offering insights into cellular diversity, gene expression profiles, and biomarker identification. The market is witnessing substantial growth driven by the expanding applications of single-cell analysis in various fields such as cancer research, immunology, neuroscience, and stem cell biology. Additionally, technological advancements in single-cell analysis platforms, coupled with increasing investments in life sciences research, are propelling market expansion.

Market Growth Drivers:

A multitude of factors propel the growth of the Single-Cell Analysis Market. The rising demand for high-resolution cellular analysis tools to decipher cellular heterogeneity in diseases like cancer and neurodegenerative disorders is a significant driver. Moreover, advancements in single-cell sequencing technologies, such as droplet-based methods and spatial transcriptomics, are expanding the scope of single-cell analysis applications. Furthermore, collaborations between academic research institutions, pharmaceutical companies, and technology providers are fostering innovation in single-cell analysis platforms, thereby driving market growth.

Market Restraints:

Despite its promising prospects, the Single-Cell Analysis Market faces certain challenges. High instrument costs and complexity in data analysis pose significant barriers to the widespread adoption of single-cell analysis technologies, particularly in resource-constrained settings. Moreover, the interpretation of single-cell data and standardization of experimental protocols remain key challenges for researchers. Additionally, concerns regarding data reproducibility and the need for robust quality control measures hinder market growth to some extent.

Market Opportunities:

The Single-Cell Analysis Market presents ample opportunities for innovation and growth. Advancements in single-cell isolation techniques, coupled with the integration of multi-omics approaches, hold promise for expanding the application spectrum of single-cell analysis in personalized medicine and drug discovery. Furthermore, the emergence of single-cell spatial profiling technologies offers new avenues for studying tissue microenvironments and cell-cell interactions in various pathological conditions. Moreover, strategic collaborations between technology developers and pharmaceutical companies to develop novel single-cell analysis assays and biomarker discovery platforms are likely to fuel market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Single-Cell Analysis Market globally?
  • How are technological advancements influencing the development and adoption of single-cell analysis technologies?
  • What are the major challenges and opportunities for market participants?
  • Which research areas and therapeutic applications offer the highest growth potential?
  • What strategies are leading companies employing to strengthen their market position and address the evolving needs of researchers and clinicians?

Competitive Intelligence and Business Strategy:

Key players in the global Single-Cell Analysis Market, including biotechnology companies, instrument manufacturers, and academic research institutions, focus on innovation, product differentiation, and strategic collaborations to maintain their competitive edge. Companies invest in developing cutting-edge single-cell analysis platforms that offer high sensitivity, throughput, and multiplexing capabilities. Additionally, emphasis on user-friendly software solutions for data analysis and visualization enhances the usability of single-cell analysis platforms, driving their adoption among researchers. Strategic partnerships with academic research centers and pharmaceutical companies facilitate technology validation and accelerate the translation of single-cell analysis findings into clinical applications.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc.
  • Qiagen N.V
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • Becton, Dickinson & Company
  • Fluidigm Corporation
  • 10x Genomics Inc.
  • BGI
  • Novogene Corporation

Single-Cell Analysis Market Research Segmentation:

By Consumables

  • Consumables

Reagents

Assay Kits

  • Instruments
  • Manual Instruments

Microscopes

Hemocytometers

Automated Instruments

Flow Cytometers

Next Generation Sequencing

PCR Systems

High-content Screening System

Cell Microarrays

Automated Cell Counters

By Application Type

  • Cancer
  • Immunology
  • Neurology
  • Stem Cell
  • Non-invasive Prenatal Diagnosis
  • In-vitro Fertilization
  • Others

By Workflow

  • Single Cell Isolation & Library Preparation
  • Downstream Analysis
  • Data Analysis

By End User

  • Academic & Research Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Consumables
      • 5.3.1.1. Reagents
      • 5.3.1.2. Assay Kits
    • 5.3.2. Instruments
      • 5.3.2.1. Manual Instruments
      • 5.3.2.2. Microscopes
      • 5.3.2.3. Hemocytometers
      • 5.3.2.4. Automated Instruments
      • 5.3.2.5. Flow Cytometers
      • 5.3.2.6. Next Generation Sequencing
      • 5.3.2.7. PCR Systems
      • 5.3.2.8. High-content Screening System
      • 5.3.2.9. Cell Microarrays
      • 5.3.2.10. Automated Cell Counters
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 6.3.1. Cancer
    • 6.3.2. Immunology
    • 6.3.3. Neurology
    • 6.3.4. Stem Cell
    • 6.3.5. Non-invasive Prenatal Diagnosis
    • 6.3.6. In-vitro Fertilization
    • 6.3.7. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application, 2024-2032

7. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Workflow

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Workflow , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Workflow , 2024-2032
    • 7.3.1. Single Cell Isolation & Library Preparation
    • 7.3.2. Downstream Analysis
    • 7.3.3. Data Analysis
  • 7.4. Y-o-Y Growth Trend Analysis By Workflow , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Workflow , 2024-2032

8. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By End-user

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By End-user, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user, 2024-2032
    • 8.3.1. Academic & Research Laboratories
    • 8.3.2. Biotechnology & Pharmaceutical Companies
    • 8.3.3. Hospitals & Diagnostic Laboratories
    • 8.3.4. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End-user, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End-user, 2024-2032

9. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Workflow
    • 10.2.5. By End-user
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By Workflow
    • 10.3.5. By End-user
  • 10.4. Key Takeaways

11. Latin America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By Workflow
    • 11.2.5. By End-user
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Application
    • 11.3.4. By Workflow
    • 11.3.5. By End-user
  • 11.4. Key Takeaways

12. Europe Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By Workflow
    • 12.2.5. By End-user
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By Workflow
    • 12.3.5. By End-user
  • 12.4. Key Takeaways

13. Asia Pacific Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. Singapore
      • 13.2.1.5. Thailand
      • 13.2.1.6. Indonesia
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of Asia Pacific
    • 13.2.2. By Product
    • 13.2.3. By Application
    • 13.2.4. By Workflow
    • 13.2.5. By End-user
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Workflow
    • 13.3.5. By End-user
  • 13.4. Key Takeaways

14. MEA Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Application
    • 14.2.4. By Workflow
    • 14.2.5. By End-user
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By Workflow
    • 14.3.5. By End-user
  • 14.4. Key Takeaways

15. Key Countries Single-Cell Analysis Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Application
      • 15.1.2.3. By Workflow
      • 15.1.2.4. By End-user
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Application
      • 15.2.2.3. By Workflow
      • 15.2.2.4. By End-user
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Application
      • 15.3.2.3. By Workflow
      • 15.3.2.4. By End-user
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Application
      • 15.4.2.3. By Workflow
      • 15.4.2.4. By End-user
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Application
      • 15.5.2.3. By Workflow
      • 15.5.2.4. By End-user
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Application
      • 15.6.2.3. By Workflow
      • 15.6.2.4. By End-user
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Application
      • 15.7.2.3. By Workflow
      • 15.7.2.4. By End-user
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Application
      • 15.8.2.3. By Workflow
      • 15.8.2.4. By End-user
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Application
      • 15.9.2.3. By Workflow
      • 15.9.2.4. By End-user
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Application
      • 15.10.2.3. By Workflow
      • 15.10.2.4. By End-user
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Application
      • 15.11.2.3. By Workflow
      • 15.11.2.4. By End-user
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Application
      • 15.12.2.3. By Workflow
      • 15.12.2.4. By End-user
  • 15.13. Singapore
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Application
      • 15.13.2.3. By Workflow
      • 15.13.2.4. By End-user
  • 15.14. Thailand
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Application
      • 15.14.2.3. By Workflow
      • 15.14.2.4. By End-user
  • 15.15. Indonesia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Application
      • 15.15.2.3. By Workflow
      • 15.15.2.4. By End-user
  • 15.16. Australia
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Application
      • 15.16.2.3. By Workflow
      • 15.16.2.4. By End-user
  • 15.17. New Zealand
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Application
      • 15.17.2.3. By Workflow
      • 15.17.2.4. By End-user
  • 15.18. GCC Countries
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Application
      • 15.18.2.3. By Workflow
      • 15.18.2.4. By End-user
  • 15.19. South Africa
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Application
      • 15.19.2.3. By Workflow
      • 15.19.2.4. By End-user
  • 15.20. Israel
    • 15.20.1. Pricing Analysis
    • 15.20.2. Market Share Analysis, 2024
      • 15.20.2.1. By Product
      • 15.20.2.2. By Application
      • 15.20.2.3. By Workflow
      • 15.20.2.4. By End-user

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Workflow
    • 16.3.5. By End-user

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. Thermo Fisher Scientific, Inc.
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. QIAGEN NV
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. Bio-Rad Laboratories Inc.
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Illumina Inc.
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. Merck KGaA
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Becton, Dickinson & Company
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Fluidigm Corporation
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. 10x Genomics, Inc.
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. BGI
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Novogene Corporation
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology